These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1141 related articles for article (PubMed ID: 1956278)

  • 1. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinguishing characteristics of idiopathic calcium oxalate kidney stone formers with low amounts of Randall's plaque.
    Wang X; Krambeck AE; Williams JC; Tang X; Rule AD; Zhao F; Bergstralh E; Haskic Z; Edeh S; Holmes DR; Herrera Hernandez LP; Lieske JC
    Clin J Am Soc Nephrol; 2014 Oct; 9(10):1757-63. PubMed ID: 25092598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Parker WR; Asplin JR
    Kidney Int; 2000 Feb; 57(2):550-60. PubMed ID: 10652032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time.
    Parks JH; Coe FL; Evan AP; Worcester EM
    Nephrol Dial Transplant; 2009 Jan; 24(1):130-6. PubMed ID: 18662977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum biochemical metabolic panel with stone composition.
    Moreira DM; Friedlander JI; Carons A; Hartman C; Leavitt DA; Smith AD; Okeke Z
    Int J Urol; 2015 Feb; 22(2):195-9. PubMed ID: 25257446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between kidney stone composition and urinary metabolic disturbances in children.
    Kirejczyk JK; Porowski T; Filonowicz R; Kazberuk A; Stefanowicz M; Wasilewska A; Debek W
    J Pediatr Urol; 2014 Feb; 10(1):130-5. PubMed ID: 23953243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease.
    Bhojani N; Paonessa JE; Hameed TA; Worcester EM; Evan AP; Coe FL; Borofsky MS; Lingeman JE
    J Urol; 2015 Nov; 194(5):1308-12. PubMed ID: 25988516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of phosphate in calcium oxalate renal stones.
    Ohman S; Larsson L; Tiselius HG
    Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():59-63. PubMed ID: 1536527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine acidification capacity in renal stone formers.
    Backman U; Danielson BG; Sohtell M
    Scand J Urol Nephrol; 1976; Suppl 35():49-61. PubMed ID: 26969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL
    Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective long-term evaluation of incomplete distal renal tubular acidosis in idiopathic calcium nephrolithiasis diagnosed by low-dose NH
    Sromicki J; Kacl G; Föhl M; Hess B
    J Nephrol; 2022 Jul; 35(6):1619-1626. PubMed ID: 34973150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.